Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov and CTIS registry records · Last verified 26 Sep 2026 · Editorial standards

At a glance

Chinese University of Hong Kong is the lead sponsor of 43 current clinical trials in our China and India registers. 31 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Esomeprazole, Nexium and Semaglutide. The most-studied condition is Reproductive Issues.

ClinicalTrials.gov trials by status

Recruiting3172%
Not yet open921%
Active, closed25%
By invitation12%

Trials by phase

Not applicable2660%
Observational1228%
Phase 225%
Phase 412%
Phase 1/212%
Phase 312%

Clinical trials sponsored by Chinese University of Hong Kong

43 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
POEM-F for Achalasia International Study NCT06042127 · Achalasia	Not applicable	Recruiting	2023-12	India, China
PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers NCT05582174 · ClinicalTrials.gov ↗ · Upper GI Bleeding, Proton Pump Inhibitors Drugs: Esomeprazole, Nexium, Vonoprazan	Phase 4	Recruiting	2023-05	China
RCT of EFTR Versus STER for GIST Treatment NCT07411118 · ClinicalTrials.gov ↗ · Small Size Gastrointestinal Stromal Tumors, GIST	Not applicable	Recruiting	2025-02	India, China
Mother-infant Microbiota Transmission and Its Link to the Health of the Baby NCT04117321 · ClinicalTrials.gov ↗ · Gut Microbiome, Mother to Child Transmission	Observational	Recruiting	2019-09	China
Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors NCT06549673 · ClinicalTrials.gov ↗ · Portal Hypertension, Cirrhosis, Varices, Esophageal	Observational	Recruiting	2025-01	India, China
EUS Guided Portal-systemic Pressure Gradient Measurement NCT04633356 · ClinicalTrials.gov ↗ · Portal Hypertension, Cirrhosis	Phase 1/2	Recruiting	2020-11	China
Diagnostic Accuracy of Capnography in Nasogastric Tube Placement NCT05817864 · ClinicalTrials.gov ↗ · Capnography, Nasogastric Tube, Diagnostic Accuracy	Observational	Recruiting	2023-07	China
Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery NCT06926374 · ClinicalTrials.gov ↗ · Colorectal Carcinoma, Rectal Prolapse, Prostate Cancer (Adenocarcinoma)	Not applicable	Recruiting	2025-03	China
Prenatal Music Exposure to Enhance Postnatal Language Development NCT07699536 · ClinicalTrials.gov ↗ · Pregnancy	Not applicable	Recruiting	2025-09	China
Advanced Translational Research on Childhood Leukemia NCT04478006 · ClinicalTrials.gov ↗ · Childhood Leukemia	Observational	Recruiting	2020-07	China
Effective Translation of Endovascular Thrombectomy Trials Into Real-world Practice in the Asia-Pacific NCT05578300 · ClinicalTrials.gov ↗ · Ischemic Stroke, Stroke, Stroke, Acute	Observational	Recruiting	2022-10	China
ACU-TENS on Pain and Stress Reduction Before and During TUGOR NCT06910540 · ClinicalTrials.gov ↗ · Oocyte Retrieival and Post Operative Pain Control, Acupuncture	Not applicable	Recruiting	2025-09	China
OTSC vs. Angiographic Embolization in Patients With Refractory Non-variceal Upper Gastrointestinal Bleeding NCT04902248 · ClinicalTrials.gov ↗ · Upper Gastrointestinal Bleeding	Not applicable	Recruiting	2021-11	China
Respiratory Virus Metagenomics After COVID-19 NCT05126589 · ClinicalTrials.gov ↗ · COVID-19 Respiratory Infection	Observational	Recruiting	2021-12	China
Impacts of HIV Treatment Regimens on Archived Drug Resistance NCT07643948 · ClinicalTrials.gov ↗ · HIV -1 Infection, Antiretroviral Therapy, Drug Resistance, Microbial	Observational	Recruiting	2025-10	China
Study Comparing Hemiarch Replacement and Hemiarch Plus Stent Implantation in Acute Aortic Dissection NCT06044259 · ClinicalTrials.gov ↗ · Aortic Dissection	Not applicable	Recruiting	2023-10	China
Theory-based Health Behaviour Change Intervention in Patients of Metabolic Syndrome With Chronic Kidney Disease NCT06527768 · ClinicalTrials.gov ↗ · Chronic Kidney Diseases, Metabolic Syndrome	Not applicable	Recruiting	2024-07	China
ESAT6/CFP10 Skin Testing for TB Infection in Rheumatologic Patients NCT06796647 · ClinicalTrials.gov ↗ · Tuberculosis (TB)	Observational	Recruiting	2025-03	China
A Novel Oral Synbiotic Formula in Reducing Advanced Adenoma Recurrence and Colorectal Neoplasia-related Bacterial Gene Markers NCT05592886 · ClinicalTrials.gov ↗ · Colorectal Neoplasms, Colorectal Adenoma, Colorectal Cancer	Not applicable	Recruiting	2022-12	China
Virtual Reality-based Sensory Stimulation for Delirium Prevention in Intensive Care Units NCT07806422 · ClinicalTrials.gov ↗ · Delirium in the Intensive Care Unit	Not applicable	Recruiting	2026-01	China
GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD) NCT05356104 · ClinicalTrials.gov ↗ · Cerebral Small Vessel Disease	Phase 2	Recruiting	2022-05	China
Comparative Effectiveness Between Indomethacin and Pancreatic Stenting in the Prevention of Post ERCP Pancreatitis NCT03713879 · ClinicalTrials.gov ↗ · Post ERCP Pancreatitis	Phase 3	Recruiting	2019-03	China
Theory-based Health Behaviour Change Intervention in Individuals of Metabolic Syndrome With Chronic Kidney Disease NCT06715735 · ClinicalTrials.gov ↗ · Chronic Kidney Diseases, Metabolic Syndrome	Not applicable	Recruiting	2024-12	China
EUS Guided Portal-systemic Pressure Gradient Measurement to Predict Treatment Response and Outcomes of Varices to Endoscopic Variceal Ligation in Patients With Chronic Hepatitis. NCT05597488 · ClinicalTrials.gov ↗ · Cirrhosis Portal	Not applicable	Recruiting	2022-11	China
Impact of Serum Progesterone Levels on Embryo Transfer Day on Clinical Pregnancy NCT07388797 · ClinicalTrials.gov ↗ · Reproductive Issues	Observational	Recruiting	2026-01	China
Awareness, Knowledge and Behavioral Seeking of Gynaecological Problems NCT07208383 · ClinicalTrials.gov ↗ · Gynecologic Disease	Observational	Recruiting	2025-10	China
HerResolve™ in Detecting the Presence of Endometriosis Among Symptomatic Women NCT07006987 · ClinicalTrials.gov ↗ · Endometriosis	Not applicable	Recruiting	2025-10	China
A Sitting Tai Chi Programme for Chronic Stroke Survivors With Post-stroke Cognitive Impairment NCT07512739 · ClinicalTrials.gov ↗ · Stroke, Cognitive Impairment	Not applicable	Recruiting	2025-10	China
COVID-19 Immunity and Changes Over Time NCT05271669 · ClinicalTrials.gov ↗ · COVID-19	Observational	Recruiting	2022-06	China
Prevention of Insomnia Using a Stepped Care Model in Adults NCT06156293 · ClinicalTrials.gov ↗ · Sleep Disturbance	Not applicable	Recruiting	2023-12	China
Factors Associated With Clinical Pregnancy Outcomes in Intrauterine Insemination (IUI) Cycles NCT07344623 · ClinicalTrials.gov ↗ · Reproductive Issues	Observational	Recruiting	2026-01	China
Standardization and Application of Pure Platelet-Rich Plasma in Improving Sperm Function NCT07348354 · ClinicalTrials.gov ↗ · Infertility	Not applicable	Not yet open	2026-01	China
Effects of Pulsed Electromagnetic Field Therapy on Meniscal Healing, Symptom Relief, and Knee Function NCT07117929 · ClinicalTrials.gov ↗ · Meniscal Tears	Not applicable	Not yet open	2025-08	China
Improving Quality of Informal Care for People With Schizophrenia NCT07781748 · ClinicalTrials.gov ↗ · Schizophrenia	Not applicable	Not yet open	2027-07	China
The Application of a Novel Endoluminal Robotic System for Colorectal Endoscopic Submucosal Dissection NCT07486180 · ClinicalTrials.gov ↗ · Early Rectal Neoplasms	Not applicable	Not yet open	2026-04	China
Female Autologous Platelet-Rich Plasma (PRP) Co-incubation With Husband's Sperm NCT07282327 · ClinicalTrials.gov ↗ · Reproductive Issues	Not applicable	Not yet open	2025-12	China
The Application of Sentire Surgical System Plus Patient Side Single Arm in Robotic Colorectal Surgery NCT07453706 · ClinicalTrials.gov ↗ · Colorectal Adenoma and Carcinoma	Not applicable	Not yet open	2026-03	China
The Efficacy and Safety of Female PRP Co-incubation With Sperm During (IUI) Cycles NCT07615634 · ClinicalTrials.gov ↗ · Reproductive Issues	Not applicable	Not yet open	2026-05	China
Effects of a Peer-facilitated, Acceptance-based Self-learning for Illness Management (PASIM) Program NCT07129369 · ClinicalTrials.gov ↗ · Psychotic Disorders, Recent-Onset Psychosis	Not applicable	Not yet open	2026-01	China
GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial NCT07613437 · ClinicalTrials.gov ↗ · Intracerebral Hemorrhage Drug: Semaglutide	Phase 2	Not yet open	2026-06	China
Impact of Chronotype-Based Time-Restricted Eating on Visceral Fat and Metabolic Health in Physically Inactive Adults With Central Obesity NCT07062315 · ClinicalTrials.gov ↗ · Central Obesity, Time Restricted Eating	Not applicable	By invitation	2025-07	China
Enhancing the Therapeutic Effect of Bracing for Adolescent Idiopathic Scoliosis With a Hybrid Bracing Protocol NCT07045337 · ClinicalTrials.gov ↗ · Adolescent Idiopathic Scoliosis (AIS)	Not applicable	Active, closed	2022-01	China
Parent-implemented Social Communication Treatment in Autism NCT05635760 · ClinicalTrials.gov ↗ · Autism, Social Communication, Speech Therapy	Not applicable	Active, closed	2022-10	China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in Chinese University of Hong Kong trials

4 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Esomeprazole1 Nexium1 Semaglutide1 Vonoprazan1

Conditions in Chinese University of Hong Kong trials

63 conditions

Reproductive Issues4Portal Hypertension2 Cirrhosis2 Stroke2 Chronic Kidney Diseases2 Metabolic Syndrome2Achalasia1Small Size Gastrointestinal Stromal Tumors1GIST1Varices, Esophageal1Upper GI Bleeding1Proton Pump Inhibitors1Infertility1Gut Microbiome1Mother to Child Transmission1Capnography1Nasogastric Tube1Diagnostic Accuracy1Colorectal Carcinoma1Rectal Prolapse1Prostate Cancer (Adenocarcinoma)1 Bladder Cancer1 Pregnancy1Childhood Leukemia1

By trial register

Register	Trials	Recruiting
Clinical trials in China	43	31
Clinical trials in India	3	3

A trial with sites in more than one country appears in each of those registers.

Questions about Chinese University of Hong Kong trials

How many clinical trials does Chinese University of Hong Kong sponsor?

Chinese University of Hong Kong is the lead sponsor of 43 current trials on ClinicalTrials.gov in our China and India registers, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Chinese University of Hong Kong trials recruiting?

Yes. 31 of its 43 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Chinese University of Hong Kong testing?

Its current trials name 4 drugs and biologicals as interventions. The most frequent are Esomeprazole (1), Nexium (1), Semaglutide (1) and Vonoprazan (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.

Chinese University of Hong Kong clinical trials